BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Influenza
,
Prostate
,
Hematopoietic cell
,
Fenofibrate
,
rs2300478
,
FGF21
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
pol polyprotein
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
CXCL11
CXCL10
FN1
CXCL9
IFNG
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_DN
GSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_DN
HALLMARK_INTERFERON_GAMMA_RESPONSE
GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY3_DN
GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_DN
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
PBMC of rhesus macaques immunized with an SIV DNA vaccine
Explore Curated Studies Results
Literature
Most Relevant Literature
Resistance to pyridine-based inhibitor KF116 reveals an unexpected role of integrase in HIV-1 Gag-Po…
SHFL inhibits enterovirus A71 infection by triggering degradation of viral 3Dpol protein via the ubi…
Effective Suppression of HIV-1 Replication by Cytotoxic T Lymphocytes Specific for Pol Epitopes in C…
HIV-1 Mutant Assembly, Processing and Infectivity Expresses Pol Independent of Gag.
Modulation of human endogenous retroviruses -H, -W and -K transcription by microbes.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Study to Assess the Acceptability of the Darunavir/Cobicistat (DRV/COBI) Fixed-dose Combination (F…
Safety and Immune Response to a Prime-Boost Vaccination Schedule in HIV-infected Patients
Vaccine Treatment for HIV-Infection
Safety and Immunogenicity of an HIV Vaccine in Normal Adult Volunteers
Phase I Study of HIV Adenoviral Vector Vaccine in Healthy Subjects Using Needle or Biojector Injecti…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ